Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Spanish Society of Nephrology (SENEFRO) commentary to the Spain GBD 2016 report: Keeping chronic kidney disease out of sight of health authorities will only magnify the problem.
Ortiz A, Sanchez-Niño MD, Crespo-Barrio M, De-Sequera-Ortiz P, Fernández-Giráldez E, García-Maset R, Macía-Heras M, Pérez-Fontán M, Rodríguez-Portillo M, Salgueira-Lazo M, Sánchez-Álvarez E, Santamaría-Olmo R, Simal-Blanco F, Pino-Pino MD. Ortiz A, et al. Nefrologia (Engl Ed). 2019 Jan-Feb;39(1):29-34. doi: 10.1016/j.nefro.2018.09.002. Epub 2018 Nov 28. Nefrologia (Engl Ed). 2019. PMID: 30503082 Free article. Review. English, Spanish.
Teaching nephrology as part of a degree in medicine.
de Arriba G, Ortiz Arduán A, Rodríguez Pérez JC, Tejedor Jorge A, Santamaría Olmo R, Rodríguez Portillo M. de Arriba G, et al. Among authors: santamaria olmo r. Nefrologia (Engl Ed). 2021 May-Jun;41(3):284-303. doi: 10.1016/j.nefro.2020.09.007. Epub 2021 Jan 5. Nefrologia (Engl Ed). 2021. PMID: 33413803 Free article. English, Spanish.
Chronic kidney disease and vascular risk - what's new?
Santamaría Olmo R, Pendón Ruiz de Mier MV, Rodelo Haad C. Santamaría Olmo R, et al. Hipertens Riesgo Vasc. 2022 Jan-Mar;39(1):3-7. doi: 10.1016/j.hipert.2022.01.001. Hipertens Riesgo Vasc. 2022. PMID: 35152979 No abstract available.
Teaching nephrology as part of a degree in medicine.
de Arriba G, Ortiz Arduán A, Rodríguez Pérez JC, Tejedor Jorge A, Santamaría Olmo R, Rodríguez Portillo M. de Arriba G, et al. Among authors: santamaria olmo r. Nefrologia (Engl Ed). 2021 May-Jun;41(3):284-303. doi: 10.1016/j.nefroe.2021.07.006. Epub 2021 Aug 6. Nefrologia (Engl Ed). 2021. PMID: 36166245 Free article.
Study of the association of markers of central and peripheral arterial stiffness with renal function in patients with arterial hypertension, diabetes mellitus and chronic kidney disease.
Perelló Martínez J, Michán Doña A, Santamaría Olmo R, Hidalgo Santiago JC, Gálvez Moral J, Gómez-Fernández P. Perelló Martínez J, et al. Among authors: santamaria olmo r. Nefrologia (Engl Ed). 2024 Nov-Dec;44(6):830-845. doi: 10.1016/j.nefroe.2024.11.018. Epub 2024 Dec 10. Nefrologia (Engl Ed). 2024. PMID: 39665943 Free article.
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial.
Heerspink HJL, Parving HH, Andress DL, Bakris G, Correa-Rotter R, Hou FF, Kitzman DW, Kohan D, Makino H, McMurray JJV, Melnick JZ, Miller MG, Pergola PE, Perkovic V, Tobe S, Yi T, Wigderson M, de Zeeuw D; SONAR Committees and Investigators. Heerspink HJL, et al. Lancet. 2019 May 11;393(10184):1937-1947. doi: 10.1016/S0140-6736(19)30772-X. Epub 2019 Apr 14. Lancet. 2019. PMID: 30995972 Clinical Trial.
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes.
Bakris GL, Agarwal R, Anker SD, Pitt B, Ruilope LM, Rossing P, Kolkhof P, Nowack C, Schloemer P, Joseph A, Filippatos G; FIDELIO-DKD Investigators. Bakris GL, et al. N Engl J Med. 2020 Dec 3;383(23):2219-2229. doi: 10.1056/NEJMoa2025845. Epub 2020 Oct 23. N Engl J Med. 2020. PMID: 33264825 Free article. Clinical Trial.
Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes.
Pitt B, Filippatos G, Agarwal R, Anker SD, Bakris GL, Rossing P, Joseph A, Kolkhof P, Nowack C, Schloemer P, Ruilope LM; FIGARO-DKD Investigators. Pitt B, et al. N Engl J Med. 2021 Dec 9;385(24):2252-2263. doi: 10.1056/NEJMoa2110956. Epub 2021 Aug 28. N Engl J Med. 2021. PMID: 34449181 Clinical Trial.
Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial.
Bakris GL, Agarwal R, Anker SD, Pitt B, Ruilope LM, Nowack C, Kolkhof P, Ferreira AC, Schloemer P, Filippatos G; on behalf of the FIDELIO-DKD study investigators; FIDELIO-DKD study investigators. Bakris GL, et al. Am J Nephrol. 2019;50(5):333-344. doi: 10.1159/000503713. Epub 2019 Oct 25. Am J Nephrol. 2019. PMID: 31655812 Free PMC article. Clinical Trial.
15 results